Pharma has much to gain from leveraging components of a virtual business model, especially as an innovative way to work with experts and partners at the right moments throughout the product lifecycle.

I write about business model strategy and execution across healthcare. Pharmaceutical executives are waking up to a hard new reality. The winds of healthcare economic change, accelerated by a ...

I write about business model strategy and execution across healthcare. The pharmaceutical industry is in the midst of profound transformation. Downward economic pressures, a tightening federal ...

Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.) ...

Causal AI for predicting clinical efficacy is currently transforming the pharma business model. The gold standard for establishing causality is the prospective, randomized, placebo-controlled ...

As digital health becomes a commoditised product, pharma is evolving from being a product based industry toward one that is one rooted in solutions. Business model disruption in pharma is now a ...

At the start of each of the last five years, the share price of Alkermes has increased. It’s the kind of steady trajectory ...